Arkolith/Insider Trading/XERS/Form 4

Persky Marla

DirectorXeris Biopharma Holdings, Inc. (XERS) · full profile →Form 4 · filed Sep 12, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$120K
Net Open-Market Flow
-$120K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 11, 2025Sell(S)16K$7.72$120K142K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001867096-25-000147) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML